Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Andrews

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|September 27, 2019
The role of ponatinib in chronic myeloid leukemia in the era of treatment free remissionClaire Andrews, Jeffrey Lipton
Frontiers in Oncology|December 4, 2023
CPX-351 in <i>FLT3</i>-mutated acute myeloid leukemiaClaire Andrews, Vinod Pullarkat, Christian Recher
Critical Reviews in Clinical Laboratory Sciences|November 9, 2020
The genomic and biological complexity of mixed phenotype acute leukemiaClaire Andrews, Anne Tierens, Mark Minden
Leukemia & Lymphoma|August 8, 2020
The successful use of <i>FLT3</i> inhibitors in <i>FLT3</i>-positive mixed phenotype acute leukemiaClaire Andrews, Wilson Lam, Hassan Sibai
Expert Review of Molecular Diagnostics|November 24, 2023
Molecular diagnostic criteria of myeloproliferative neoplasmsClaire Andrews, Eibhlin Conneally, Stephen E Langabeer
Journal of Sports Sciences|March 19, 2011
Comparison of advanced and intermediate 200-m backstroke swimmers' dominant and non-dominant shoulder entry angles across various swimming speedsClaire Andrews, James Bakewell, Joanna C Scurr
British Journal of Haematology|June 23, 2020
Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literatureClaire Andrews, Dawn Maze, Tracy Murphy, et al.
Psychology, Health & Medicine|March 22, 2016
Which behaviours? Identifying the most common and burdensome behaviour changes in amyotrophic lateral sclerosisSophie Claire Andrews, Alexia Pavlis, Mathew Staios, et al.
Case Reports in Hematology|January 30, 2018
Late Emergence of an Imatinib-Resistant <i>ABL1</i> Kinase Domain Mutation in a Patient with Chronic Myeloid LeukemiaMireille Crampe, Claire Andrews, Anne Fortune, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2026
Neuropsychological subtypes of incident mild cognitive impairment and mild neurocognitive disorder in a population-based cohort of older adultsSophie Claire Andrews, Ranmalee Eramudugolla, Craig Sinclair, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|September 27, 2019
The role of ponatinib in chronic myeloid leukemia in the era of treatment free remissionClaire Andrews, Jeffrey Lipton
Frontiers in Oncology|December 4, 2023
CPX-351 in <i>FLT3</i>-mutated acute myeloid leukemiaClaire Andrews, Vinod Pullarkat, Christian Recher
Critical Reviews in Clinical Laboratory Sciences|November 9, 2020
The genomic and biological complexity of mixed phenotype acute leukemiaClaire Andrews, Anne Tierens, Mark Minden
Leukemia & Lymphoma|August 8, 2020
The successful use of <i>FLT3</i> inhibitors in <i>FLT3</i>-positive mixed phenotype acute leukemiaClaire Andrews, Wilson Lam, Hassan Sibai
Expert Review of Molecular Diagnostics|November 24, 2023
Molecular diagnostic criteria of myeloproliferative neoplasmsClaire Andrews, Eibhlin Conneally, Stephen E Langabeer
Journal of Sports Sciences|March 19, 2011
Comparison of advanced and intermediate 200-m backstroke swimmers' dominant and non-dominant shoulder entry angles across various swimming speedsClaire Andrews, James Bakewell, Joanna C Scurr
British Journal of Haematology|June 23, 2020
Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literatureClaire Andrews, Dawn Maze, Tracy Murphy, et al.
Psychology, Health & Medicine|March 22, 2016
Which behaviours? Identifying the most common and burdensome behaviour changes in amyotrophic lateral sclerosisSophie Claire Andrews, Alexia Pavlis, Mathew Staios, et al.
Case Reports in Hematology|January 30, 2018
Late Emergence of an Imatinib-Resistant <i>ABL1</i> Kinase Domain Mutation in a Patient with Chronic Myeloid LeukemiaMireille Crampe, Claire Andrews, Anne Fortune, et al.
Journal of Alzheimer'S Disease : JAD|January 28, 2026
Neuropsychological subtypes of incident mild cognitive impairment and mild neurocognitive disorder in a population-based cohort of older adultsSophie Claire Andrews, Ranmalee Eramudugolla, Craig Sinclair, et al.
Pageof 2